Exact Sciences Corp., a leader in advanced cancer diagnostics, announced that company management will participate in the following conference and invited investors to participate by webcast.
MADISON, Wis., May 2, 2022 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced that company management will participate in the following conference and invited investors to participate by webcast.
- BofA Securities Healthcare Conference, Las Vegas
Fireside Chat on Wednesday, May 11, 2022 at 5:00 p.m. ET
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company’s website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815
View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-may-investor-conference-301536912.html
SOURCE Exact Sciences Corporation
Company Codes: NASDAQ-SMALL:EXAS
